AL
Alector, Inc.
ALEC · NASDAQ
$2.04 -7.08% (-$0.15)
1M -0.49%
Market Cap $225.9M
P/E Ratio -
Div. Yield -
ROE 531.04%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 16.30x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 46.00%
Book val. growth 47.72%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 360.92%
FCF margin 1,142.55%
Net margin 850.13%
Quality
1 /100
Poor ROIC 67.73%
Asset turnover 0.07x
ROE 531.04%
Debt
100 /100
Low Current ratio 5.26x
Debt/Equity N/A
Debt/Assets N/A
Stability
53 /100
Moderate Beta 0.58x
Profitable years 0
Rev. volatility 41.77%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ALEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Arnon Rosenthal
Employees
103
Headquarters
South San Francisco
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report